{"id":"https://openalex.org/W2809677663","doi":"https://doi.org/10.2337/db18-1367-p","title":"Diabetes Retinopathy (DR) Relates to Complication Risk in Young Persons with T1D","display_name":"Diabetes Retinopathy (DR) Relates to Complication Risk in Young Persons with T1D","publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2809677663","doi":"https://doi.org/10.2337/db18-1367-p","mag":"2809677663"},"language":"en","primary_location":{"id":"doi:10.2337/db18-1367-p","doi":"https://doi.org/10.2337/db18-1367-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1367-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026867046","display_name":"Michelle L. Katz","orcid":"https://orcid.org/0000-0002-5441-5071","observed_orcids":["https://orcid.org/0000-0002-5441-5071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MICHELLE KATZ","raw_affiliation_strings":["Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009528569","display_name":"George Liang King","orcid":"https://orcid.org/0000-0002-0335-5881","observed_orcids":["https://orcid.org/0000-0002-0335-5881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GEORGE L. KING","raw_affiliation_strings":["Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011697010","display_name":"Jennifer K. Sun","orcid":"https://orcid.org/0000-0003-0915-6303","observed_orcids":["https://orcid.org/0000-0003-0915-6303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JENNIFER SUN","raw_affiliation_strings":["Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069785394","display_name":"Lori M. Laffel","orcid":"https://orcid.org/0000-0002-9675-3001","observed_orcids":["https://orcid.org/0000-0002-9675-3001","https://orcid.org/0000-0003-2202-492X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LORI M. LAFFEL","raw_affiliation_strings":["Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09745265,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"67","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.875,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.875,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.09309999644756317,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9390000104904175},{"id":"https://openalex.org/keywords/youth-onset-diabetes","display_name":"youth-onset diabetes","score":0.8119999766349792},{"id":"https://openalex.org/keywords/diabetes-complications","display_name":"diabetes complications","score":0.703000009059906},{"id":"https://openalex.org/keywords/diabetic-neuropathy","display_name":"diabetic neuropathy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pulse-wave-analysis","display_name":"pulse wave analysis","score":0.6919999718666077},{"id":"https://openalex.org/keywords/aortic-stiffness","display_name":"aortic stiffness","score":0.5929999947547913},{"id":"https://openalex.org/keywords/endothelial-activation","display_name":"endothelial activation","score":0.6909999847412109},{"id":"https://openalex.org/keywords/e-selectin","display_name":"E-selectin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.6010000109672546},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9760000109672546},{"id":"https://openalex.org/keywords/isoprostanes","display_name":"isoprostanes","score":0.7860000133514404},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9729999899864197},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8169999718666077},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9003453254699707},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6864854097366333},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6602237224578857},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.5775577425956726},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.5083195567131042},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5052364468574524},{"id":"https://openalex.org/C2778313320","wikidata":"https://www.wikidata.org/wiki/Q550455","display_name":"Retinopathy","level":3,"score":0.45499640703201294},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.443266898393631},{"id":"https://openalex.org/C2776391266","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Fundus (uterus)","level":2,"score":0.4172897934913635},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36424338817596436},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3393979072570801},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19816672801971436}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db18-1367-p","doi":"https://doi.org/10.2337/db18-1367-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1367-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2132234017","https://openalex.org/W2969078648","https://openalex.org/W2047263739","https://openalex.org/W2809370729","https://openalex.org/W7161684403","https://openalex.org/W4365138112","https://openalex.org/W2317647381","https://openalex.org/W2558929192","https://openalex.org/W4400112179","https://openalex.org/W1932468131"],"abstract_inverted_index":{"Young":[0,168],"persons":[1,18,169,213],"who":[2],"develop":[3],"DR":[4,26,51,70,93,106,132,149,171,206,222,230,237,244],"may":[5],"represent":[6],"a":[7],"high-risk":[8],"group":[9],"for":[10,140,175],"early":[11],"development":[12],"of":[13,30,186],"other":[14,31,209],"complications.":[15,180],"In":[16],"young":[17,212],"with":[19,96,110,135,153,170,214],"youth-onset":[20],"T1D,":[21],"we":[22],"evaluated":[23],"associations":[24],"between":[25],"status":[27,104,150],"and":[28,60,64,83,102,119,123,145,162,178,188,208,221,324],"markers":[29,126,185],"T1D":[32,44,99,142],"complication":[33],"risk.":[34],"Youth":[35],"(N=127),":[36],"mean":[37,43],"age":[38],"21.7":[39],"y":[40,47],"(range":[41,48],"10.7-31.9),":[42],"onset":[45],"6.3":[46],"0.5-17.6)":[49],"underwent":[50],"assessment":[52],"(ETDRS-protocol":[53],"7":[54],"field":[55],"fundus":[56],"photos);":[57],"renal,":[58,177],"neuropathic,":[59,176],"CVD":[61,179],"risk":[62,65,174],"screenings;":[63],"screening":[66],"by":[67,114,147],"blood/urine":[68],"studies.":[69],"was":[71,94,108,133,151],"classified":[72],"as":[73],"none":[74],"(No":[75],"DR,":[76,81,89],"37%),":[77],"mild":[78,86],"nonproliferative":[79],"(Mild":[80],"46%),":[82],"more":[84],"than":[85],"NPDR":[87],"(Advanced":[88],"17%).":[90],"More":[91],"severe":[92],"associated":[95,109,134,152],"greater":[97,131],"age,":[98,141],"duration,":[100,143],"A1c,":[101],"weight":[103],"(Table).":[105],"severity":[107],"neuropathy,":[111],"vascular":[112],"stiffness":[113],"pulse":[115],"wave":[116],"(aortic":[117],"AIx),":[118],"inflammatory,":[120],"oxidative":[121,189],"stress,":[122],"endothelial":[124],"activation":[125],"(CRP,":[127],"isoprostane,":[128],"e-selectin).":[129],"Paradoxically,":[130],"less":[136],"PAI-1.":[137],"After":[138],"adjustment":[139],"weight,":[144],"A1c":[146],"ANCOVA,":[148],"differences":[154],"in":[155,193,211],"cooling":[156],"threshold":[157],"(7.6,":[158],"8.6,":[159],"12.3,":[160],"p=.0003)":[161],"e-selectin":[163],"(39.8,":[164],"34.0,":[165],"46.0,":[166],"p=.02).":[167],"have":[172],"high":[173],"While":[181],"PAI-1":[182],"is":[183],"lower,":[184],"inflammation":[187],"stress":[190],"are":[191],"higher":[192],"this":[194],"group.":[195],"Optimal":[196],"glycemic":[197],"control":[198],"must":[199],"be":[200],"prioritized":[201],"to":[202],"prevent":[203],"or":[204,233,235,240,242,247,249,253],"delay":[205],"progression":[207],"complications":[210],"DR.":[215],"Unadjusted":[216],"Associations":[217],"Between":[218],"Clinical":[219],"Factors":[220],"Status,":[223],"*indicates":[224],"ln":[225],"transformed":[226],"p":[227],"valueClinical":[228],"FactorNo":[229],"(n=47)":[231],"Mean":[232,239,246],"Median":[234,241,248],"%Mild":[236],"(n=59)":[238],"%Advanced":[243],"(n=21)":[245],"%P":[250],"value":[251],"ANOVA":[252],"Chi-squareAge":[254],"(yrs)/T1D":[255],"Duration":[256],"(yrs)/A1c":[257],"(%)18.9/13.2/8.022.6/15.8/8.625.8/19.6/9.1<.0001/<.0001/.03Sex":[258],"(%":[259],"male)/Overweight/obese":[260],"(%)60/3236/6148/57.05/.009Urinary":[261],"Albumin":[262],"Excretion*":[263],"/eGFR":[264],"per":[265],"1.73m27.3/128.26.4/141.29.3/140.6.04/.02Neuropathy":[266],"(MNSI)/Warm":[267],"Threshold/Cold":[268],"Threshold1.3/14.6/7.11.9/15.3/8.63.0/18.2/13.4.004/.005/<.001Mean":[269],"SBP/Mean":[270],"DBP/Aortic":[271],"AIx110/68/2.0112/71/9.0115/74/11.1.2/.008/.003PAI1*":[272],"(ng/ml)/CRP*":[273],"(mg/l)/IGF1":[274],"(ng/ml)36.8/0.8/207.526.2/2.5/160.614.4/2.7/138.8<.001/.002/.002E-selectin(ng/ml)/Urine":[275],"isoprostane*":[276],"(ng/ml)40.8/0.2034.5/0.3441.8/0.40.1/.002":[277],"Disclosure":[278],"M.":[279],"Katz:":[280],"None.":[281],"G.L.":[282],"King:":[283],"Research":[284,296],"Support;":[285,297],"Self;":[286,292,298,314,321],"Sanofi-Aventis.":[287],"J.":[288],"Sun:":[289],"Other":[290,312],"Relationship;":[291,313],"Novartis":[293],"Pharmaceuticals":[294],"Corporation.":[295],"Genentech,":[299],"Inc.,":[300,328,337,344],"Optovue,":[301],"Incorporated,":[302],"Boston":[303],"Micromachines":[304],"Corporation,":[305,332,335,339],"Adaptive":[306],"Sensory":[307],"Technology,":[308],"Kalvista":[309],"Pharmaceuticals,":[310,343],"Inc..":[311],"Novo":[315,326],"Nordisk":[316,327],"Inc.":[317],"L.M.":[318],"Laffel:":[319],"Consultant;":[320],"Eli":[322],"Lilly":[323],"Company,":[325],"Sanofi":[329],"US,":[330],"MannKind":[331],"Roche":[333],"Diagnostics":[334],"Dexcom,":[336],"Insulet":[338],"AstraZeneca,":[340],"Boehringer":[341],"Ingelheim":[342],"Johnson":[345,347],"&":[346],"Diabetes":[348],"Institute,":[349],"LLC..":[350]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-06-29T00:00:00"}